📉 Metabolic health & insulin sensitivity
4 mechanistic pathways · 66 options
Insulin resistance sits upstream of most of what people come to this Vault for — fat that won't move, low testosterone, PCOS, fatty liver, cardiovascular risk, and probably a chunk of cognitive decline. It is also the most reversible thing on this list. Fasting insulin and HbA1c together tell you more than fasting glucose alone, which stays normal for years while insulin climbs to keep it that way.
The pathways
AMPK activation & cellular fuel sensing
AMPK is the switch that flips when cellular energy is low — it increases glucose uptake, fat oxidation and mitochondrial biogenesis while switching off storage. Exercise and fasting activate it, and so does everything in this list.
Incretin & satiety signaling
GLP-1 and GIP are released by the gut in response to food. They amplify glucose-dependent insulin secretion — meaning they raise insulin only when glucose is high, which is why they don't cause hypoglycemia the way sulfonylureas do.
Glucose disposal, absorption & the post-meal curve
Post-meal glucose excursions drive glycation, oxidative stress and endothelial damage — and HbA1c can look acceptable while the spikes are doing real harm. Flattening the curve is a separate goal from lowering the average.
Hepatic fat & fatty liver
The liver is where insulin resistance usually starts. Fat accumulating in hepatocytes impairs insulin's ability to suppress glucose output, which raises circulating insulin, which drives more storage. Break that loop and the systemic picture follows.
Test before you choose a pathway
Every route below can be argued for on mechanism. Only bloodwork tells you which one is actually your problem — and picking the wrong pathway is the most common reason someone concludes "none of this works". Across all 4 pathways, these are the 15 markers worth having in front of you first.
Ordered together:
📉 Insulin Resistance Deep Dive💉 On a GLP-1 (Semaglutide / Tirzepatide)🫀 Fatty Liver & Liver HealthWhat actually decides this outcome, in order of size
The largest randomized experiment ever run on this goal reported something most pages leave out: the same intervention did different things to different people. Ranked by how much of the outcome each one owns:
- Which of the two proven interventions fits you, because they are not interchangeable. Long-term effects AND effect heterogeneity of lifestyle and metformin on diabetes incidence were reported over 21 years of the Diabetes Prevention Program Knowler 2025. Heterogeneity is the headline: an average effect is a summary of subgroups that responded differently, and knowing which subgroup you are in is worth more than any product on the four pathways below.
- Which test you are being judged by, because they disagree. Fasting glucose and glycated hemoglobin are discordant often enough that the discordance has been studied in its own right Abdul Murad 2021. A normal fasting glucose does not exclude an abnormal HbA1c, and a person can be labeled prediabetic by one and normal by the other on the same morning.
- Whether the liver is involved, because it changes the pathway. Advanced fibrosis and steatosis are found in type 2 diabetes at a prevalence that is not visible from the glucose numbers Makker 2021. That is the specific reason Hepatic fat & fatty liver exists as a separate route rather than as a footnote.
- What the outcome actually is, stated honestly. Metformin and lifestyle were examined against mortality in the Diabetes Prevention Program and its outcomes study Lee 2021. Diabetes incidence and mortality are different endpoints, and a page that quotes one while implying the other is doing the reader a disservice.
- The compounds, last, and the most-sold botanical here has a pharmacokinetic problem that is also its mechanism. Berberine is poorly absorbed and is converted by gut bacteria into an intestine-absorbable form Feng 2015, and repeated administration inhibits human cytochrome P450 enzymes Guo 2012. That second fact belongs on the label of every berberine product and appears on none of them.
The order to run these in, and what has to be true first
Two tests, one clinical conversation, then exactly one pathway. Running two pathways at once over one winter is how somebody ends up unable to say what worked.
- One requisition, six analytes. HbA1c (Hemoglobin A1c) with a fasting glucose from the Comprehensive Metabolic Panel (CMP), because they disagree Abdul Murad 2021. Fasting Insulin to describe the compensation that precedes the glucose rise. Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) with ApoB (Apolipoprotein B), and GGT (Gamma-Glutamyl Transferase) as the cheapest signal that the liver is participating.
- Read the result as a subgroup rather than as a label. The 21-year data is explicit that response varied across participants Knowler 2025, so a single threshold crossing is a starting position rather than a verdict, and a repeat at 12 weeks is more informative than a second opinion about the first value.
- Take the lifestyle arm seriously before the pharmacology, because it is the arm with the longest follow-up. That is not a moral point, it is where the data is Knowler 2025 Lee 2021, and it is free relative to everything below.
- Then route to exactly one pathway. Fasting insulin high with a normal HbA1c is AMPK activation & cellular fuel sensing. Post-meal symptoms with normal fasting numbers is Glucose disposal, absorption & the post-meal curve. Appetite and intake as the dominant problem is Incretin & satiety signaling. A raised GGT or a fatty liver on imaging is Hepatic fat & fatty liver.
- Berberine and Dihydroberberine are the shelf's first stop and carry a real interaction risk. Cytochrome P450 inhibition after repeated dosing has been measured in humans Guo 2012, which makes it a poor companion for statins, several antihypertensives and anything with a narrow therapeutic index. The dihydro form exists because of the absorption problem Feng 2015.
- Metformin is a prescription with the longest human record on this hub and a monitorable cost. Its effect on cobalamin status has been reviewed Fituri 2023, which is why Vitamin B12 belongs in the annual draw of anybody taking it.
- The incretin agents are the most effective and the most clinical. Semaglutide has randomized evidence in non-alcoholic steatohepatitis Newsome 2021, which is the hub's clearest example of one drug crossing two of these pathways. The detail belongs at Appetite & satiety signaling and Incretin & satiety signaling.
- Akkermansia muciniphila is the interesting end and it is still one small trial. Supplementation was tested in overweight and obese human volunteers Depommier 2019. It is a proof-of-concept study, not a treatment, and the distinction is the whole difference between this hub's evidence and its shelf.
What gets bought for this that cannot move it
The category that fails structurally is the glucose-disposal supplement bought by somebody with normal insulin sensitivity. These agents work by increasing an uptake or blunting an absorption that is already adequate. There is no deficit to correct, and the honest prediction is a flat HbA1c at 12 weeks. The two interventions with 21-year outcome data are a behavior change and an old prescription drug Knowler 2025, and neither is on any shelf under this hub.
Berberine is the option here whose marketing most exceeds its safety file. It is sold as nature's metformin, and the comparison collapses at the point that matters: metformin's interactions and monitoring are documented and taught Fituri 2023, while berberine's cytochrome P450 inhibition Guo 2012 reaches the reader through neither the label nor a pharmacist. A supplement that inhibits drug-metabolizing enzymes is a drug interaction that nobody is recording.
A normal panel is the finding, not a wasted test. This is the most useful sentence on the hub. A normal HbA1c with a normal fasting insulin closes a question that would otherwise absorb years of purchases, and the discordance work is the reason both belong on the same form rather than one Abdul Murad 2021.
And if the goal underneath this one is different, say so. Wanting to be smaller rather than more insulin-sensitive is Lose fat, which is a different set of levers with different read-outs. Fatigue with normal glucose is Energy & fatigue. Cholesterol and particle count is ApoB & LDL particle reduction. And a diagnosed diabetes on treatment is a clinical relationship that no supplement page substitutes for.
How you would know it was working, on a real read-out and a real timescale
The prediction this hub makes is that two numbers, drawn twelve weeks apart, will settle which pathway is yours and whether anything you bought did something. If HbA1c (Hemoglobin A1c) and Fasting Insulin are both unchanged after a quarter, the intervention did not work, whatever the scales said.
- HbA1c (Hemoglobin A1c) at baseline and at 12 weeks, never sooner. Twelve weeks because glycated hemoglobin integrates glucose exposure over the lifespan of the circulating red cell population, so an earlier repeat is reading the previous quarter.
- Fasting Insulin with the same draws, and C-Peptide, Serum if insulin is being injected or if the values look impossible. Fasting insulin rises years before glucose does, which is why it is the sensitive end of this hub, and C-peptide distinguishes endogenous secretion from administered insulin.
- Fructosamine instead of HbA1c where red cell turnover is abnormal. Anemia, hemoglobin variants, recent transfusion and hemolysis all corrupt glycated hemoglobin while leaving glucose unchanged, and fructosamine reads a shorter window that does not depend on the red cell.
- GGT (Gamma-Glutamyl Transferase) with the Comprehensive Metabolic Panel (CMP) once, to decide whether the liver pathway applies. Advanced fibrosis exists in this population at a prevalence the glucose numbers do not reveal Makker 2021.
- Vitamin B12 once a year on Metformin. The cobalamin effect is established enough to have been reviewed Fituri 2023, and the neuropathy it can cause is mistaken for diabetic neuropathy, which is the specific reason it belongs here rather than in a footnote.
What will fool you. HbA1c falls with anything that shortens red cell lifespan, including iron deficiency being treated, so a flattering result can be a hematology finding Abdul Murad 2021. Fasting insulin is highly variable between draws and is affected by the previous evening's meal. Weight loss from any cause improves every number on this list, so a supplement started during a deliberate change of diet will take the credit Knowler 2025. And berberine will lower glucose while quietly changing the exposure of other drugs Guo 2012, which is a result that looks like success on this panel and like a problem somewhere else.
Sources read for these sections
- Knowler WC. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes and Endocrinology 2025 · PMID 40311647
- Lee CG. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care 2021 · PMID 34697033
- Abdul Murad NA, et al. Discordance between Fasting Plasma Glucose (FPG) and HbA1c in Diagnosing Diabetes and Pre-diabetes in The Malaysian Cohort. Journal of the ASEAN Federation of Endocrine Societies 2021 · PMID 34966195
- Newsome PN. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. New England Journal of Medicine 2021;384(12):1113-1124 · PMID 33185364
- Makker J, et al. Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study. World Journal of Gastroenterology 2021 · PMID 33642826
- Fituri S, et al. Impact of metformin treatment on cobalamin status in persons with type 2 diabetes. Nutrition Reviews 2023 · PMID 37167532
- Guo Y, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology 2012 · PMID 21870106
- Feng R, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Scientific Reports 2015 · PMID 26174047
- Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine 2019 · PMID 31263284
You have the pathways. Here is the stack.
The Metabolic Health Blueprint names the one compound I would start with in each of these 4 pathways, what it was chosen over, and why — plus 21 options to swap in or stack on top, every one of them priced and linked.
Open The Metabolic Health Blueprint →You know the goal. Skool has the plan.
Every pathway above is one arm of The Metabolic health & insulin sensitivity Blueprint. The members' version has the sequence they run in, what stacks with what, and the markers that tell you to keep going or stop — alongside the Bloodwork Protocols.
Open The Metabolic health & insulin sensitivity Blueprint in Skool →$10/mo, cancel anytime.
← Open Metabolic health & insulin sensitivity in the interactive Vault · All 21 goals
Frequently asked questions
This goal is broken into 4 distinct mechanistic pathways — AMPK activation & cellular fuel sensing; Incretin & satiety signaling; Glucose disposal, absorption & the post-meal curve; Hepatic fat & fatty liver — across 66 compounds and supplements. Each pathway is a different argument about how the body gets there, so the useful question is which one matches where you are actually stuck.
The one that matches your actual limitation, which bloodwork usually settles faster than guessing. An appetite drug does nothing for someone who already undereats, and a thyroid intervention does nothing if your thyroid is fine. Each pathway page lists the markers that tell you whether it is your problem.
No. The 4 pathways are listed in mechanistic order, not by strength of evidence, and neither are the 66 options inside them. A lot of what works in this space has never had the trial run, and sorting by trial count would bury exactly the compounds you came looking for.
Where this goes next
Everything above is the free case for Metabolic health & insulin sensitivity. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.